High-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity.
Effects of High-Intensity Interval Training on Body Composition, Inflammatory Biomarkers, and Circulating MyomiRs in Adults With Clinical Obesity: A Randomized Controlled Trial.
This randomized controlled trial evaluates the effects of high-intensity interval training (HIIT) on body composition, inflammatory biomarkers, and circulating microRNAs in adults with clinical obesity. Circulating microRNAs are small regulatory molecules that may reflect exercise-induced adaptations and inter-tissue communication related to skeletal muscle and metabolic health. The study investigates whether exercise-induced changes in adiposity are accompanied by changes in inflammatory status and circulating microRNA profiles associated with skeletal muscle adaptations and metabolic health.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Clinical obesity is characterized by excessive adiposity accompanied by impaired metabolic health and chronic low-grade inflammation. Emerging evidence suggests that obesity is also associated with alterations in circulating molecular biomarkers that may influence skeletal muscle function and inter-tissue communication.
High-intensity interval training (HIIT) is an effective exercise strategy for improving body composition and cardiometabolic health; however, the molecular mechanisms underlying these adaptations remain incompletely understood. In particular, limited information is available regarding the response of circulating muscle-related microRNAs (myomiRs) to exercise interventions in adults with clinical obesity.
This randomized controlled trial is designed to investigate physiological and molecular adaptations to HIIT in adults with clinical obesity. The study will examine the relationship between changes in adiposity, systemic inflammation, and circulating microRNA expression following a supervised exercise intervention. Circulating microRNAs may provide insight into exercise-responsive biological pathways and represent potential biomarkers of skeletal muscle adaptation and metabolic health.
The findings may improve understanding of the molecular mechanisms associated with exercise-induced health benefits in clinical obesity and contribute to the identification of novel biomarkers relevant to obesity management and precision exercise medicine.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Sofia Uribe-Cerda, MSc.
- Numero di telefono: +56 975396081
- Email: s.uribecerda@uandresbello.edu
Backup dei contatti dello studio
- Nome: Mayalen Valero Breton, PhD.
- Numero di telefono: +56 992204392
- Email: mayalen.valero@unab.cl
Luoghi di studio
-
-
Metropolitan Region
-
Santiago, Metropolitan Region, Chile
- Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello.
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Adults aged 20 to 39 years.
- Clinical obesity defined primarily by body fat percentage (>29% in women and >20% in men), complemented by body mass index (BMI ≥30 kg/m²) and waist-to-height ratio (≥0.55).
- Low habitual physical activity level, defined as not meeting the criteria for moderate or high physical activity according to the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
Exclusion Criteria:
- Cardiovascular disease.
- Metabolic disease (e.g., type 2 diabetes mellitus or dyslipidemia).
- Inflammatory or autoimmune disease (e.g., rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, or psoriasis).
- Current smoking.
- Chronic medication use that may affect metabolic or inflammatory outcomes.
- Pregnancy and lactation.
- Participation in a structured exercise program within the previous 6 months. Contraindications to high-intensity exercise.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: High-Intensity Interval Training (HIIT)
Participants assigned to this arm will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during 8 weeks. Each training session will last approximately 30 minutes and include a warm-up, high-intensity intervals performed at approximately 90% of maximal power output, active recovery periods, and a cool-down. All sessions will be supervised by qualified personnel to ensure participant safety and adherence to the protocol. |
Participants will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during eight weeks. Each session will last approximately 30 minutes and consist of a warm-up, ten 1-minute high-intensity intervals performed at approximately 90% of maximal power output, interspersed with 1-minute active recovery periods, and a cool-down. Training intensity will be reassessed midway through the intervention to ensure appropriate progression. All sessions will be supervised by qualified personnel to promote adherence, proper exercise execution, and participant safety. |
|
Nessun intervento: Control
Participants assigned to this arm will maintain their habitual lifestyle without participating in a structured exercise program during the intervention period. Educational materials on healthy lifestyle habits will be provided at the end of the study. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Total Body Fat Mass Assessed by Bioelectrical Impedance Analysis
Lasso di tempo: Change from baseline to Week 8
|
Total body fat mass (kg) will be assessed using bioelectrical impedance analysis and compared between baseline and post-intervention measurements. |
Change from baseline to Week 8
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Plasma Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) concentration Assessed by ELISA
Lasso di tempo: From baseline to Week 8
|
Plasma IL-1β concentration (pg/mL) and TNF-α concentration (pg/mL) measured by enzyme-linked immunosorbent assay (ELISA). |
From baseline to Week 8
|
|
Circulating Myo-MicroRNAs
Lasso di tempo: from enrollment to the end of treatment at 8 weeks
|
Change in circulating expression of miR-1, miR-133, and miR-206 quantified by RT-qPCR. |
from enrollment to the end of treatment at 8 weeks
|
|
Peak Oxygen Uptake (VO₂peak)
Lasso di tempo: From baseline to Week 8
|
Change in cardiorespiratory fitness assessed by peak oxygen uptake during an incremental cycling test. |
From baseline to Week 8
|
|
Handgrip Strength
Lasso di tempo: From baseline to Week 8
|
Change in maximal handgrip strength assessed using a hydraulic hand dynamometer. |
From baseline to Week 8
|
|
Maximal Voluntary Isometric Contraction (MVC)
Lasso di tempo: From baseline to Week 8
|
Change in maximal isometric strength of the knee extensor muscles measured by dynamometry. |
From baseline to Week 8
|
|
Health-Related Quality of Life Assessed Using the 36-Item Short Form Health Survey (SF-36)
Lasso di tempo: From baseline to Week 8
|
Change in health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life. |
From baseline to Week 8
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 64B2025
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .